Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Pestrin

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Cancer Management and Research|December 29, 2010
Role of lapatinib in the first-line treatment of patients with metastatic breast cancerCatherine Oakman, Marta Pestrin, Elena Zafarana, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2007
Clinical decision making in breast cancer: TAM and aromatase inhibitors for older patients -- a jungle?Laura Biganzoli, Sara Licitra, Wederson Claudino, et al.
Cancers|November 28, 2013
Significance of micrometastases: circulating tumor cells and disseminated tumor cells in early breast cancerCatherine Oakman, Marta Pestrin, Silvia Bessi, et al.
Critical Reviews in Oncology/Hematology|February 24, 2007
Selection of chemotherapeutic drugs in adjuvant programs based on molecular profiles: where do we stand?Laura Biganzoli, Wederson M Claudino, Marta Pestrin, et al.
Breast (Edinburgh, Scotland)|August 28, 2007
Using specific cytotoxics with a targeted mindAngelo Di Leo, Wederson M Claudino, Marta Pestrin, et al.
Cancer Letters|May 25, 2005
PTEN and Egr-1 expression in thyroid proliferative lesionsCarla Di Loreto, Gianluca Tell, Marta Pestrin, et al.
Critical Reviews in Oncology/Hematology|September 3, 2008
Taxanes in the elderly: can we gain as much and be less toxic?Laura Biganzoli, Sara Licitra, Erica Moretti, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2008
Topoisomerase II alpha as a marker predicting anthracyclines' activity in early breast cancer patients: ready for the primetime?Angelo Di Leo, Laura Biganzoli, Wederson Claudino, et al.
Cancers|March 28, 2014
Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?Natalie Turner, Marta Pestrin, Francesca Galardi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2007
Metabolomics: available results, current research projects in breast cancer, and future applicationsWederson Marcos Claudino, Alessandro Quattrone, Laura Biganzoli, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Cancer Management and Research|December 29, 2010
Role of lapatinib in the first-line treatment of patients with metastatic breast cancerCatherine Oakman, Marta Pestrin, Elena Zafarana, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2007
Clinical decision making in breast cancer: TAM and aromatase inhibitors for older patients -- a jungle?Laura Biganzoli, Sara Licitra, Wederson Claudino, et al.
Cancers|November 28, 2013
Significance of micrometastases: circulating tumor cells and disseminated tumor cells in early breast cancerCatherine Oakman, Marta Pestrin, Silvia Bessi, et al.
Critical Reviews in Oncology/Hematology|February 24, 2007
Selection of chemotherapeutic drugs in adjuvant programs based on molecular profiles: where do we stand?Laura Biganzoli, Wederson M Claudino, Marta Pestrin, et al.
Breast (Edinburgh, Scotland)|August 28, 2007
Using specific cytotoxics with a targeted mindAngelo Di Leo, Wederson M Claudino, Marta Pestrin, et al.
Cancer Letters|May 25, 2005
PTEN and Egr-1 expression in thyroid proliferative lesionsCarla Di Loreto, Gianluca Tell, Marta Pestrin, et al.
Critical Reviews in Oncology/Hematology|September 3, 2008
Taxanes in the elderly: can we gain as much and be less toxic?Laura Biganzoli, Sara Licitra, Erica Moretti, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2008
Topoisomerase II alpha as a marker predicting anthracyclines' activity in early breast cancer patients: ready for the primetime?Angelo Di Leo, Laura Biganzoli, Wederson Claudino, et al.
Cancers|March 28, 2014
Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?Natalie Turner, Marta Pestrin, Francesca Galardi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2007
Metabolomics: available results, current research projects in breast cancer, and future applicationsWederson Marcos Claudino, Alessandro Quattrone, Laura Biganzoli, et al.
Pageof 4